Suchergebnisse - "Abdellatif, Ahmed A H"

PubPharm (107)

1

Development of oral formulation of Lepidium seeds significantly decreases the high blood glucose levels in diabetic rats : in vitro formulation and in vivo antidiabetic performance

enthalten in: Drug development and industrial pharmacy | 2024

von Aldosari, B. | Abdellatif, A. | Almurshedi, A. | +6

2

Targeted Nanoparticles : the Smart Way for the Treatment of Colorectal Cancer

enthalten in: AAPS PharmSciTech | 2024

von Abdellatif, A. | Alshubrumi, A. | Younis, M.

3

Targeted Nanoparticles: the Smart Way for the Treatment of Colorectal Cancer

enthalten in: AAPS PharmSciTech | 2024

von Abdellatif, A. | Alshubrumi, A. | Younis, M.

4

Self-assembling Organogels Loaded with Tenoxicam for Local Intensive Pain and Inflammation Cure : In Vitro and In Vivo Correlation

enthalten in: AAPS PharmSciTech | 2024

von Osman, S. | Yassin, T. | Abdelzaher, A. | +8

5

Self-assembling Organogels Loaded with Tenoxicam for Local Intensive Pain and Inflammation Cure: In Vitro and In Vivo Correlation

enthalten in: AAPS PharmSciTech | 2024

von Osman, S. | Yassin, T. | Abdelzaher, A. | +8

6

Doxorubicin-sanguinarine nanoparticles : formulation and evaluation of breast cancer cell apoptosis and cell cycle

enthalten in: Drug development and industrial pharmacy | 2024

von El-Readi, M. | Abdulkarim, M. | Abdellatif, A. | +7

7

Synthesis and characterization of magnetic Ag-Fe3O4polymer hybrid nanocomposite systems with promising antibacterial application

enthalten in: Drug development and industrial pharmacy | 2023

von Aldosari, B. | Abd El-Aal, M. | Abo Zeid, E. | +4

8

Evaluation of the anticancer activity of Origanum Marjoram as a safe natural drink for daily use

enthalten in: Drug development and industrial pharmacy | 2023

von Abdellatif, A. | Alsharidah, M.

9

Non-coding RNA-directed therapeutics in lung cancer : Delivery technologies and clinical applications

enthalten in: Colloids and surfaces. B, Biointerfaces | 2023

von Abdellatif, A. | Scagnetti, G. | Younis, M. | +10

10

Corrigendum to "Anti- E. coli immunoglobulin yolk (IgY) : Reduction of pathogen receptors and inflammation factors could be caused by decrease in E. coli load" [Heliyon 9(3) (February 21, 2023) e13876]>

enthalten in: Heliyon | 2023

von Bouazzaoui, A. | Bogari, N. | Al-Allaf, F. | +8

ErratumFor: Heliyon. 2023 Feb 21;9(3):e13876. - PMID 36873547

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]